Pluribus Labs’s C.H. Robinson CHRW Stock Holding History

Pluribus Labs’s Portfolio CHRW Stock Details CHRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$229K	Buy	+2,261	New	+$236K	0.42%	82

Other funds holding CHRW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pluribus Labs's CHRW Position: Q2 2022 in Review

Pluribus Labs opened a new position in C.H. Robinson (CHRW) in Q2 2022: 2,261 shares worth $229K. The stake represents 0.42% of the portfolio and ranks #82 among its holdings.

647 funds tracked by Wall St. Rank hold CHRW as of Q2 2022.

Pluribus Labs held 2,261 shares of C.H. Robinson worth $229K as of Q2 2022.
C.H. Robinson was a new Pluribus Labs position in Q2 2022.
C.H. Robinson made up 0.42% of Pluribus Labs's portfolio in Q2 2022, its #82 holding.
647 funds tracked by Wall St. Rank held C.H. Robinson as of Q2 2022.

Based on Pluribus Labs's 13F filing for Q2 2022, filed 12 Aug 2022.